We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Infective Endocarditis in High-Income Countries.
- Authors
Nappi, Francesco; Martuscelli, Giorgia; Bellomo, Francesca; Avtaar Singh, Sanjeet Singh; Moon, Marc R.
- Abstract
Infective endocarditis remains an illness that carries a significant burden to healthcare resources. In recent times, there has been a shift from Streptococcus sp. to Staphylococcus sp. as the primary organism of interest. This has significant consequences, given the virulence of Staphylococcus and its propensity to form a biofilm, rendering non-surgical therapy ineffective. In addition, antibiotic resistance has affected treatment of this organism. The cohorts at most risk for Staphylococcal endocarditis are elderly patients with multiple comorbidities. The innovation of transcatheter technologies alongside other cardiac interventions such as implantable devices has contributed to the increased risk attributable to this cohort. We examined the pathophysiology of infective endocarditis carefully. Inter alia, the determinants of Staphylococcus aureus virulence, interaction with host immunity, as well as the discovery and emergence of a potential vaccine, were investigated. Furthermore, the potential role of prophylactic antibiotics during dental procedures was also evaluated. As rates of transcatheter device implantation increase, endocarditis is expected to increase, especially in this high-risk group. A high level of suspicion is needed alongside early initiation of therapy and referral to the heart team to improve outcomes.
- Subjects
INFECTIVE endocarditis; HIGH-income countries; ARTIFICIAL implants; OLDER patients; DRUG resistance in bacteria; ENDOCARDITIS
- Publication
Metabolites (2218-1989), 2022, Vol 12, Issue 8, p682
- ISSN
2218-1989
- Publication type
Article
- DOI
10.3390/metabo12080682